Delivery Order SPE2DB24D3014-SPE2DB25FKTNS
Award Date
5/29/25
Potential Completion Date
5/30/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,547.13, is for the delivery of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 8, 2025. There is no set-aside designation for this contract. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $2,062.84 and a period of performance through May 15, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and there is no information provided...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,542.20, is for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. The contract has a completion date of February 25, 2025 and is a firm fixed-price delivery order. There is no set-aside designation indicated for this award. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $2,358.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product, with a performance period through December 20, 2023. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product, with a ceiling value of $6,648.97. The contract is a Firm Fixed Price arrangement with a period of performance ending on June 12, 2025. This contract is not designated as a set-aside and was competitively awarded....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of a prescription medication called MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. The contract has a firm fixed price of $1,647.75 and a completion date of July 10, 2025. This award is not associated with a set-aside program, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and the contract is a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,547.13, is for the delivery of the drug MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. The contract is a firm fixed-price delivery order with an ultimate completion date of April 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of pharmaceutical products. The contract, valued at $3,975.04, is for the delivery of MYFEMBREE 40 MG-1 MG-0.5 MG tablets in quantities of 28 per package, with an ultimate completion date of October 15, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation and a leading global pharmaceutical sourcing and distribution services company. The $2,542.89 firm fixed price contract is for the delivery of the pharmaceutical product MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. The contract does not have a set-aside designation and is scheduled for completion on April 11, 2024. Amerisourcebergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MYFEMBREE, a specialty medication, and has a ceiling value of $1,632.41. The contract is a firm fixed-price Indefinite Delivery Vehicle (IDV) with a period of performance through January 2025. The contract is not designated as a set-aside and was awarded through open competition....